E. Brendan Magrab

E. Brendan Magrab

Directeur Général chez
Transpharmative Advisors LLC
60 ans
Health Technology
Government
Consumer Services

Profil

E.
Brendan Magrab
is President & Chief Executive Officer at Transpharmative Advisors LLC since 2013.
Mr. Magrab is Chief Executive Officer & Director at Epalex Corp.
since 2019.
Former roles include Director at Inhibitor Therapeutics, Inc. in 2019, Vice President-Intellectual Property at Zoetis Products LLC from 2000 to 2004, Patent Examiner at the US Patent & Trademark Office, EVP-Commercial Operations & General Counsel at URL Pharma, Inc. from 2004 to 2013, and Law Clerk at the United States Court of Appeals for the Federal Circuit.
Education includes undergraduate studies at the University of Virginia and graduate studies at Georgetown University Law Center.

Postes actifs de E. Brendan Magrab

SociétésPosteDébut
Transpharmative Advisors LLC
Directeur Général 01/01/2013
Directeur Général 01/01/2019

Anciens postes connus de E. Brendan Magrab

SociétésPosteFin
HEDGEPATH PHARMACEUTICALS INC Président 15/04/2019
Conseiller Juridique Général 01/02/2013
Corporate Officer/Principal 01/09/2004
Conseiller Juridique Général -
Corporate Officer/Principal -
Voir l'expérience en détail de E. Brendan Magrab

Formation de E. Brendan Magrab

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

27

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées9

Health Technology

Government

Consumer Services

Health Technology

Government

Health Technology

Consumer Services

Transpharmative Advisors LLC

Commercial Services

  1. Bourse
  2. Insiders
  3. E. Brendan Magrab